Other authors have confirmed that HE4 and ROMA had very high specificity but lower sensitivity than CA125 and RMI, at least in premenopausal women; however, they showed comparable sensitivity in postmenopausal women and proved valuable in distinguishing benign ovarian tumours or endometriosis from OC [29]. This evidence concerns the gene WFDC2 and ovarian benign neoplasm.